rs727502780

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_006885.4(ZFHX3):​c.10142_10165delGGCAACTACAGCAGCAGCAGCAGC​(p.Arg3381_Gln3388del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000444 in 1,599,342 control chromosomes in the GnomAD database, including 3 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 3 hom. )

Consequence

ZFHX3
NM_006885.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:1

Conservation

PhyloP100: 7.12

Publications

3 publications found
Variant links:
Genes affected
ZFHX3 (HGNC:777): (zinc finger homeobox 3) This gene encodes a transcription factor with multiple homeodomains and zinc finger motifs, and regulates myogenic and neuronal differentiation. The encoded protein suppresses expression of the alpha-fetoprotein gene by binding to an AT-rich enhancer motif. The protein has also been shown to negatively regulate c-Myb, and transactivate the cell cycle inhibitor cyclin-dependent kinase inhibitor 1A (also known as p21CIP1). This gene is reported to function as a tumor suppressor in several cancers, and sequence variants of this gene are also associated with atrial fibrillation. Multiple transcript variants expressed from alternate promoters and encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
ZFHX3-AS1 (HGNC:56033): (ZFHX3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_006885.4
BP6
Variant 16-72788110-TGCTGCTGCTGCTGCTGTAGTTGCC-T is Benign according to our data. Variant chr16-72788110-TGCTGCTGCTGCTGCTGTAGTTGCC-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 18167.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000363 (55/151470) while in subpopulation SAS AF = 0.00229 (11/4794). AF 95% confidence interval is 0.00129. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZFHX3NM_006885.4 linkc.10142_10165delGGCAACTACAGCAGCAGCAGCAGC p.Arg3381_Gln3388del disruptive_inframe_deletion Exon 10 of 10 ENST00000268489.10 NP_008816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZFHX3ENST00000268489.10 linkc.10142_10165delGGCAACTACAGCAGCAGCAGCAGC p.Arg3381_Gln3388del disruptive_inframe_deletion Exon 10 of 10 1 NM_006885.4 ENSP00000268489.5

Frequencies

GnomAD3 genomes
AF:
0.000363
AC:
55
AN:
151352
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000330
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000389
Gnomad SAS
AF:
0.00229
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000399
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.000558
AC:
134
AN:
240058
AF XY:
0.000668
show subpopulations
Gnomad AFR exome
AF:
0.0000657
Gnomad AMR exome
AF:
0.000206
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000499
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000462
Gnomad OTH exome
AF:
0.000846
GnomAD4 exome
AF:
0.000452
AC:
655
AN:
1447872
Hom.:
3
AF XY:
0.000520
AC XY:
374
AN XY:
719724
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33248
American (AMR)
AF:
0.000250
AC:
11
AN:
43990
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25822
East Asian (EAS)
AF:
0.00109
AC:
43
AN:
39476
South Asian (SAS)
AF:
0.00243
AC:
206
AN:
84906
European-Finnish (FIN)
AF:
0.0000199
AC:
1
AN:
50270
Middle Eastern (MID)
AF:
0.00210
AC:
12
AN:
5716
European-Non Finnish (NFE)
AF:
0.000305
AC:
337
AN:
1104522
Other (OTH)
AF:
0.000651
AC:
39
AN:
59922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000363
AC:
55
AN:
151470
Hom.:
0
Cov.:
32
AF XY:
0.000351
AC XY:
26
AN XY:
74080
show subpopulations
African (AFR)
AF:
0.000145
AC:
6
AN:
41346
American (AMR)
AF:
0.000329
AC:
5
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.000390
AC:
2
AN:
5132
South Asian (SAS)
AF:
0.00229
AC:
11
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.000399
AC:
27
AN:
67662
Other (OTH)
AF:
0.000476
AC:
1
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000287

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Prostate cancer, somatic Pathogenic:1
Apr 01, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Uncertain:1
Feb 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 04, 2022
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
7.1
Mutation Taster
=72/128
disease causing (long InDel)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727502780; hg19: chr16-72822009; API